]. R. Vandenberghe, Amyloid PET in clinical practice: Its place in the multidimensional space of Alzheimer's disease, NeuroImage: Clinical, vol.2, issue.1
DOI : 10.1016/j.nicl.2013.03.014

J. Haad, D. J. Selkoe, C. L. Masters, R. Cappai, K. J. Barnham et al., The aloid hhpothesis of Alzheiee's disease: ppogess aad ppoles on the road to therapeutics Moleeulaa ehaisss fo Alzheiee's disease: implications for neuroimaging and therapeutics, Science. J. Neurochem, vol.297, pp.97-1700, 2002.

H. Crystal, D. Dickson, P. Fuld, D. Masur, R. Scott et al., Clinico-pathologic studies in deeeetia: odeeeted suujeets ith pathologiall ofied Alzheiee's disease, Neurology, pp.38-1682, 1988.

R. Katzman, R. Terry, R. Deteresa, T. Brown, P. Davies et al., Clinical, pathological, and neurochemical changes in dementia: a subgroup with preserved mental status and numerous neocortical plaques Frequency of stages of Alzheimer-related lesions in different age categories Tangles and plaques in nondemented aging and « preclinical » Alzheiee's disease Imaging brain aaloid i Alzheiee's disease with Pittsburgh Compound-B, Preclinical properties of 18F- AV-45: a PET agent for Abeta plaques in the brain, pp.50-1887, 1988.

D. F. Wong, P. B. Rosenberg, Y. Zhou, A. Kumar, V. Raymont et al., In Vivo Imaging of Amyloid Deposition in Alzheimer Disease Using the Radioligand 18F-AV-45 (Flobetapir F 18), Journal of Nuclear Medicine, vol.51, issue.6, pp.51-913, 2010.
DOI : 10.2967/jnumed.109.069088

K. Herholz and K. Ebmeier, Cliial aaloid iagig i Alzheiee's disease, Laaet Neuuol, pp.667-670, 2011.

G. W. Small, V. Kepe, L. M. Ercoli, P. Siddarth, S. Y. Bookheimer et al., PET of Brain Amyloid and Tau in Mild Cognitive Impairment, New England Journal of Medicine, vol.355, issue.25, pp.355-2652, 2006.
DOI : 10.1056/NEJMoa054625

W. E. Klunk, Amyloid imaging as a biomarker for cerebral ??-amyloidosis and risk prediction for Alzheimer dementia, Neurobiology of Aging, vol.32, issue.1, pp.20-36, 2011.
DOI : 10.1016/j.neurobiolaging.2011.09.006

H. A. Archer, P. Edison, D. J. Brooks, J. Barnes, C. Frost et al., Amyloid load and eeeal attoph i Alzheiee's disease: aa C-PIB positron emission tomography study, Ann. Neurol, pp.60-145, 2006.

M. A. Mintun, G. N. Larossa, Y. I. Sheline, C. S. Dence, S. Y. Lee et al., [11C]PIB in a nondemented population: Potential antecedent marker of Alzheimer disease, Neurology, vol.67, issue.3, pp.67-446, 2006.
DOI : 10.1212/01.wnl.0000228230.26044.a4

C. C. Rowe, S. Ng, U. Ackermann, S. J. Gong, K. Pike et al., Imaging beta-amyloid burden in aging and dementia, Neurology, pp.68-1718, 2007.

N. Nelissen, M. Vandenbulcke, K. Fannes, A. Verbruggen, R. Peeters et al., Abeta amyloid deposition in the language system and how the brain responds, p.130, 2007.

H. J. Aizenstein, R. D. Nebes, J. A. Saxton, J. C. Price, C. A. Mathis et al., Frequent Amyloid Deposition Without Significant Cognitive Impairment Among the Elderly, Archives of Neurology, vol.65, issue.11, pp.65-1509, 2008.
DOI : 10.1001/archneur.65.11.1509

C. R. Jack, V. J. Lowe, M. L. Senjem, S. D. Weigand, B. J. Kemp et al., 11C PiB and sttuutuual MRI ppoide opleeeetaaa ifoatio i iagig of Alzheiee's disease aad amnestic mild cognitive impairment, pp.131-665, 2008.

M. Storandt, M. A. Mintun, D. Head, and J. C. Morris, Cognitive decline and brain volume loss as signatures of cerebral amyloid-beta peptide deposition identified with Pittsburgh compound B: cognitive decline associated with Abeta deposition, Arch. Neurol, pp.66-1476, 2009.

B. C. Dickerson, A. Bakkour, D. H. Salat, E. Feczko, J. Pacheco et al., The Cortical Signature of Alzheimer's Disease: Regionally Specific Cortical Thinning Relates to Symptom Severity in Very Mild to Mild AD Dementia and is Detectable in Asymptomatic Amyloid-Positive Individuals, Cerebral Cortex, vol.19, issue.3, pp.497-510, 2009.
DOI : 10.1093/cercor/bhn113

P. Bourgeat, G. Chételat, V. L. Villemagne, J. Fripp, P. Raniga et al., Beta-amyloid burden in the temporal neocortex is related to hippocampal atrophy in elderly subjects without dementia, Neurology, pp.74-121, 2010.

S. Hatashita and H. Yaasaki, Clinically Different Stages of Alzheimer's Disease Associated by Amyloid Deposition with [11C]-PIB PET Imaging, Journal of Alzheimer's Disease, vol.21, issue.3, pp.995-1003, 2010.
DOI : 10.3233/JAD-2010-100222

J. C. Morris, C. M. Roe, C. Xiong, A. M. Fagan, A. M. Goate et al., APOE predicts amyloid-beta but not tau Alzheimer pathology in cognitively normal aging, Ann. Neurol, pp.67-122, 2010.

A. Okello, J. Koivunen, P. Edison, H. A. Archer, F. E. Turkheimer et al., Conversion of amyloid positive and negative MCI to AD over 3 years: An 11C-PIB PET study, Neurology, vol.73, issue.10, pp.73-754, 2009.
DOI : 10.1212/WNL.0b013e3181b23564

W. J. Jagust, D. Baad, K. Chee, N. L. Foste, S. M. Laadau et al., The Alzheimer's Disease Neuroimaging Initiative positron emission tomography core, Alzheimer's & Dementia, vol.6, issue.3, pp.221-229, 2010.
DOI : 10.1016/j.jalz.2010.03.003

H. Quiglee, S. J. Collo, and J. T. O-'bbiee, PET imaging of brain amyloid in dementia: a review, International Journal of Geriatric Psychiatry, vol.46, issue.(Suppl 2), pp.991-999, 2011.
DOI : 10.1002/gps.2640

R. Vandenberghe, K. Van-laere, A. Ivanoiu, E. Salmon, C. Bastin et al., 18F- flutemetamol amyloid imaging in Alzheimer disease and mild cognitive impairment: a phase 2 trial, Ann. Neurol, pp.68-319, 2010.

V. L. Villeage, R. S. Mulligaa, S. Pejoska, K. Oog, G. Joes et al., Copaaiso of 11C-PiB and 18F-florbetaben for A? iagig i ageig aad Alzheiee's disease, Eu. J. Nul. Med. Mol. Imaging, pp.39-983, 2012.

K. A. Johnson, S. Minoshima, N. I. Bohnen, K. J. Donohoe, N. L. Foster et al., Appropriate use criteria for amyloid PET: A report of the Amyloid Imaging Task Force, the Soiet of Nulea Mediie aad Moleulaa IIagig, aad the Alzheiee's Assoiatio, Alzheimers Dement, 2013.

E. C. Mormino, M. G. Brandel, C. M. Madison, G. D. Rabinovici, S. Marks et al., Not quite PIB-positive, not quite PIB-negative: Slight PIB elevations in elderly normal control subjects are biologically relevant, NeuroImage, vol.59, issue.2, pp.59-1152, 2012.
DOI : 10.1016/j.neuroimage.2011.07.098

P. Ediso, R. Hiz, and D. J. Bbooks, Teehhial aspeets of aloid iagig fo Alzheiee's disease, Alzheimers Res Ther, vol.3, issue.25, 2011.

N. Villain, G. Chételat, B. Grassiot, P. Bourgeat, G. Jones et al., Regional dynamics of amyloid-? depositio i health eldeel, ild ogitie ipaieet aad Alzheiee's disease: a voxelwise PiB-PET longitudinal study, pp.135-2126, 2012.

A. S. Fleisher, K. Chen, Y. T. Quiroz, L. J. Jakimovich, M. G. Gomez et al., Florbetapir PET analysis of amyloid-?? deposition in the presenilin 1 E280A autosomal dominant Alzheimer's disease kindred: a cross-sectional study, The Lancet Neurology, vol.11, issue.12, pp.1057-1065, 2012.
DOI : 10.1016/S1474-4422(12)70227-2

P. Edison, R. Hinz, A. Ramlackhansingh, J. Thomas, G. Gelosa et al., Can targetto-pons ratio be used as a reliable method for the analysis of [11C]PIB brain scans?, Neuroimage, pp.60-1716, 2012.

M. M. Mielke, H. J. Wiste, S. D. Weigand, D. S. Knopman, V. J. Lowe et al., Indicators of amyloid burden in a population-based study of cognitively normal elderly, Neurology, vol.79, issue.15, pp.79-1570, 2012.
DOI : 10.1212/WNL.0b013e31826e2696

E. M. Reiman, K. Chen, X. Liu, D. Bandy, M. Yu et al., Fibrillar amyloid-beta burden in ogitiel oal people at leeels of geeeti isk fo Alzheiee's disease

V. L. Villemagne, K. E. Pike, G. Chételat, K. A. Ellis, R. S. Mulligan et al., Longitudinal assessment of A?? and cognition in aging and Alzheimer disease, Annals of Neurology, vol.29, issue.1, pp.69-181, 2011.
DOI : 10.1002/ana.22248

K. Kantarci, V. Lowe, S. A. Przybelski, S. D. Weigand, M. L. Senjem et al., APOE modifies the association between A? load and cognition in cognitively normal older adults, Neurology, pp.78-232, 2012.

A. S. Fleisher, K. Chen, X. Liu, N. Ayutyanont, A. Roontiva et al., Apolipoprotein E ??4 and age effects on florbetapir positron emission tomography in healthy aging and Alzheimer disease, Neurobiology of Aging, vol.34, issue.1, pp.1-12, 2013.
DOI : 10.1016/j.neurobiolaging.2012.04.017

P. M. Doraiswamy, R. A. Sperling, R. E. Coleman, K. A. Johnson, E. M. Reiman et al., Amyloid-?? assessed by florbetapir F 18 PET and 18-month cognitive decline: A multicenter study, Neurology, vol.79, issue.16, 2012.
DOI : 10.1212/WNL.0b013e3182661f74

A. Perrotin, E. C. Mormino, C. M. Madison, A. O. Hayenga, and W. J. Jagust, Subjective Cognition and Amyloid Deposition Imaging, Archives of Neurology, vol.69, issue.2, pp.69-223, 2012.
DOI : 10.1001/archneurol.2011.666

URL : https://hal.archives-ouvertes.fr/inserm-00728999

R. E. Amariglio, J. A. Becker, J. Carmasin, L. P. Wadsworth, N. Lorius et al., Subjective cognitive complaints and amyloid burden in cognitively normal older individuals, Neuropsychologia, vol.50, issue.12, pp.50-2880, 2012.
DOI : 10.1016/j.neuropsychologia.2012.08.011

G. Chételat, V. L. Villemagne, P. Bourgeat, K. E. Pike, G. Jones et al., Relationship between atrophy and beta-amyloid deposition in Alzheimer disease, Ann. Neurol, pp.67-317, 2010.

L. Mosconi, J. O. Rinne, W. H. Tsui, V. Berti, Y. Li et al., Increased fibrillar amyloid-?? burden in normal individuals with a family history of late-onset Alzheimer's, Proceedings of the National Academy of Sciences, vol.107, issue.13, pp.5949-5954, 2010.
DOI : 10.1073/pnas.0914141107

C. Xiong, C. M. Roe, V. Buckles, A. Fagan, D. Holtzman et al., Role of Family History for Alzheimer Biomarker Abnormalities in the Adult Children Study, Archives of Neurology, vol.68, issue.10, pp.68-1313, 2011.
DOI : 10.1001/archneurol.2011.208

N. M. Scheinin, S. Aalto, J. Kaprio, M. Koskenvuo, I. Räihä et al., Early detection of Alzheimer disease: 11C-PiB PET in twins discordant for cognitive impairment, Neurology, vol.77, issue.5, pp.77-453, 2011.
DOI : 10.1212/WNL.0b013e318225118e

D. M. Rentz, J. J. Locascio, J. A. Becker, E. K. Moran, E. Eng et al., Cognition, reserve and amyloid deposition in normal aging, Annals of Neurology, pp.67-353, 2010.
DOI : 10.1002/ana.21904

S. M. Laadau, S. M. Maaks, E. C. Moio, G. D. Raaioii, H. Oh et al., Assoiatio of lifetime cognitive engagement and low ?-amyloid deposition, Arch. Neurol, pp.69-623, 2012.

K. Y. Liang, M. A. Mintun, A. M. Fagan, A. M. Goate, J. M. Bugg et al., Exercise aad Alzheiee's disease ioaakees i ogitiel oal oldee adults, AA. Neuol, pp.311-318

D. Head, J. M. Bugg, A. M. Goate, A. M. Fagan, M. A. Mintun et al., Exercise Engagement as a Moderator of the Effects of APOE Genotype on Amyloid Deposition, Arch. Neurol, pp.69-636, 2012.

Y. Stern, What is cognitive reserve? Theory and research application of the reserve concept, Journal of the International Neuropsychological Society, vol.8, issue.03, pp.448-460, 2002.
DOI : 10.1017/S1355617702813248

W. E. Klunk, J. C. Price, C. A. Mathis, N. D. Tsopelas, B. J. Lopresti et al., Amyloid Deposition Begins in the Striatum of Presenilin-1 Mutation Carriers from Two Unrelated Pedigrees, Journal of Neuroscience, vol.27, issue.23, pp.27-6174, 2007.
DOI : 10.1523/JNEUROSCI.0730-07.2007

V. L. Villemagne, S. Ataka, T. Mizuno, W. S. Brooks, Y. Wada et al., High striatal amyloid beta-peptide deposition across different autosomal Alzheimer disease mutation types, Arch. Neurol, pp.66-1537, 2009.

W. D. Knight, A. A. Okello, N. S. Ryan, F. E. Turkheimer, S. R. Martinez-de-llano et al., Carbon-11-Pittsburgh compound B positron emission tomography imaging of amyloid deposition in presenilin 1 mutation carriers, Brain, vol.134, issue.1, pp.134-293, 2011.
DOI : 10.1093/brain/awq310

J. O. Rinne and K. Någren, Positron emission tomography in at risk patients and in the progression of ild ogitie ipaiet to Alzheiee's disease, J. Alzheiees Dis

V. Berti, B. Nacmias, S. Bagnoli, and S. Sorbi, Alzheiee's disease: geeeti asis aad aloid imaging as endophenotype, Q J Nucl Med Mol Imaging, pp.55-225, 2011.

R. J. Bateman, C. Xiong, T. L. Benzinger, A. M. Fagan, A. Goate et al., Clinical and biomarker changes in dominantly inheeited Alzheiee's disease, N. Egl, J. Med, pp.795-804

E. M. Reiman, Y. T. Quiroz, A. S. Fleisher, K. Chen, C. Velez-pardo et al., Brain imaging and fluid biomarker analysis in young adults at genetic risk for autosomal dominant Alzheimer's disease in the presenilin 1 E280A kindred: a case-control study, The Lancet Neurology, vol.11, issue.12, pp.1048-1056, 2012.
DOI : 10.1016/S1474-4422(12)70228-4

R. Craig-sshapio, A. M. Fagaa, and D. M. Holtzaa, Bioakees of Alzheiee's disease, Neuuoiol. Dis, vol.35, pp.128-140, 2009.

G. B. Frisoni, N. C. Fox, C. R. Jack, P. Scheltens, and P. M. Thompson, The clinical use of structural MRI in Alzheimer disease, Nature Reviews Neurology, vol.15, issue.2, pp.67-77, 2010.
DOI : 10.1038/nrneurol.2009.215

C. R. Jack, D. S. Knopman, W. J. Jagust, L. M. Shaw, P. S. Aisen et al., Hypothetical model of dddai ioaakees of the Alzheiee's pathologial assade, Laaet Neuol

R. C. Peteesee, Alzheiee's disease: ppogess i ppeditio

M. W. Weiner, P. S. Aisen, C. R. Jack, W. J. Jagust, J. Q. Trojanowski et al., The Alzheiee's disease euuoiagig iitiatie: ppogess epot aad futuue plaas, Alzheiees Dement, pp.202-211, 2010.

E. C. Mormino, J. T. Kluth, C. M. Madison, G. D. Rabinovici, S. L. Baker et al., Episodic memory loss is related to hippocampal-mediated beta-amyloid deposition in elderly subjects, pp.132-1310, 2009.

R. A. Speelig, P. S. Laaiolette, K. O-'keefe, J. O-'bbiee, D. M. Reetz et al., Aloid deposition is associated with impaired default network function in older persons without dementia, pp.63-178, 2009.

M. Storandt, D. Head, A. M. Fagan, D. M. Holtzman, and J. C. Morris, Toward a multifactorial model of Alzheimer disease, Neurobiology of Aging, vol.33, issue.10, pp.33-2262, 2012.
DOI : 10.1016/j.neurobiolaging.2011.11.029

S. M. Resnick, J. Sojkova, Y. Zhou, Y. An, W. Ye et al., Longitudinal cognitive decline is associated with fibrillar amyloid-beta measured by [11C]PiB, Neurology, vol.74, issue.10, pp.74-807, 2010.
DOI : 10.1212/WNL.0b013e3181d3e3e9

S. M. Resnick and J. Sojkova, Amyloid imaging and memory change for prediction of cognitive impairment, Alzheimer's Research & Therapy, vol.3, issue.1, 2011.
DOI : 10.1186/alzrt62

N. L. Marchant, B. R. Reed, C. S. Decarli, C. M. Madison, M. W. Weiner et al., Cerebrovascular disease, beta-amyloid, and cognition in aging, Neurobiology of Aging, vol.33, issue.5, pp.33-2012
DOI : 10.1016/j.neurobiolaging.2011.10.001

K. E. Pike, G. Savage, V. L. Villemagne, S. Ng, S. A. Moss et al., Beta-amyloid imaging and memory in non-deeeted idiiduals: eideeee fo ppeeliial Alzheiee's disease, BBai, pp.130-2837, 2007.

G. Chételat, V. L. Villemagne, K. E. Pike, K. A. Ellis, P. Bourgeat et al., Independent contribution of temporal beta-amyloid deposition to memory decline in the pre-dementia phase of Alzheiee's disease

D. M. Rentz, R. E. Amariglio, J. A. Becker, M. Frey, L. E. Olson et al., Face-name associative memory performance is related to amyloid burden in normal elderly, Neuropsychologia, vol.49, issue.9, pp.49-2776, 2011.
DOI : 10.1016/j.neuropsychologia.2011.06.006

H. Oh, C. Habeck, C. Madison, and W. Jagust, Covarying alterations in A?? deposition, glucose metabolism, and gray matter volume in cognitively normal elderly, Human Brain Mapping, vol.29, issue.Part 4, 2012.
DOI : 10.1002/hbm.22173

H. Oh, C. Madison, T. J. Haight, C. Markley, and W. J. Jagust, Effects of age and ??-amyloid on cognitive changes in normal elderly people, Neurobiology of Aging, vol.33, issue.12, pp.33-2746, 2012.
DOI : 10.1016/j.neurobiolaging.2012.02.008

K. E. Pike, K. A. Ellis, V. L. Villemagne, N. Good, G. Chételat et al., Cognition and betaaaloid i peliial Alzheiee's disease: data ffo the AIBL stud, Neuopsshologia, pp.2384-2390, 2011.

G. Chételat, V. L. Villemagne, K. E. Pike, J. Baron, P. Bourgeat et al., Larger temporal volume in elderly with high versus low beta-amyloid deposition, Brain, vol.133, issue.11, pp.133-3349, 2010.
DOI : 10.1093/brain/awq187

R. , L. Joie, A. Perrotin, L. Barré, C. Hommet et al., Region-Specific Hierarchy between Atrophy, Hypometabolism, and ?-Amyloid (A? Load i Alzheiee's Disease Dementia, J. Neurosci, pp.32-16265, 2012.

T. Hedden, K. R. Van-dijk, J. A. Becker, A. Mehta, R. A. Sperling et al., Disruption of functional connectivity in clinically normal older adults harboring amyloid burden, J. Neurosci, pp.29-12686, 2009.

J. A. Becker, T. Hedden, J. Carmasin, J. Maye, D. M. Rentz et al., Amyloid-?? associated cortical thinning in clinically normal elderly, Annals of Neurology, vol.9, issue.6, pp.69-1032, 2011.
DOI : 10.1002/ana.22333

G. Chételat, B. Desgranges, B. Landeau, F. Mézenge, J. B. Poline et al., Direct voxel-ased opaaiso etteee ggee attee hpoetaaolis aad atoph i Alzheiee's disease, pp.131-60, 2008.

J. C. Morris, C. M. Roe, E. A. Grant, D. Head, M. Storandt et al., Pittsburgh Compound B Imaging and Prediction of Progression From Cognitive Normality to Symptomatic Alzheimer Disease, Archives of Neurology, vol.66, issue.12, pp.66-1469, 2009.
DOI : 10.1001/archneurol.2009.269

G. Chételat, V. L. Villemagne, N. Villain, G. Jones, K. A. Ellis et al., Accelerated cortical atrophy in cognitively normal elderly with high ??-amyloid deposition, Neurology, vol.78, issue.7, pp.78-477, 2012.
DOI : 10.1212/WNL.0b013e318246d67a

N. M. Scheinin, S. Aalto, J. Koikkalainen, J. Lötjönen, M. Karrasch et al., Follow-up of [11C]PIB uptake and brain volume in patients with Alzheimer disease and controls, Neurology, vol.73, issue.15, pp.73-1186, 2009.
DOI : 10.1212/WNL.0b013e3181bacf1b

D. Tosun, N. Schuff, C. A. Mathis, W. Jagust, and M. W. Weiner, Spatial patterns of brain amyloidbeta burden and atrophy rate associations in mild cognitive impairment, p.134, 2011.

A. D. Leo, I. Yaaosk, N. Paaikshak, X. Hua, S. Lee et al., Alzheiee's disease neuroimaging initiative: a one-year follow up study using tensor-based morphometry correlating degenerative rates, biomarkers and cognition, pp.45-645, 2009.

X. Hua, D. P. Hibar, S. Lee, A. W. Toga, C. R. Jack-jr et al., Sex and age differences in atrophic rates: an ADNI study with n=1368 MRI scans, Neurobiology of Aging, vol.31, issue.8, pp.31-1463, 2010.
DOI : 10.1016/j.neurobiolaging.2010.04.033

J. M. Schott, J. W. Bartlett, N. C. Fox, and J. Barnes, Increased brain atrophy rates in cognitively normal older adults with low cerebrospinal fluid A??1-42, Annals of Neurology, vol.6, issue.6, pp.68-825, 2010.
DOI : 10.1002/ana.22315

D. Tosun, N. Schuff, L. M. Shaw, J. Q. Trojanowski, and M. W. Weiner, Relationship between CSF ioaakes of Alzheiee's disease aad ates of egioal otial thiig i ADNI data, J

G. Mckhann, D. Drachman, M. Folstein, R. Katzman, D. Price et al., Clinical diagnosis of Alzheiee's disease: epot of the NINCDS-ADRDA Work Group under the auspices of Depaateet of Health aad Huaa Seeies Task Foe o Alzheiee's Disease, Neuuolog, pp.939-944, 1984.

B. Dubois, H. H. Feldman, C. Jacova, S. T. Dekosky, P. Barberger-gateau et al., Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS???ADRDA criteria, The Lancet Neurology, vol.6, issue.8, pp.734-746, 2007.
DOI : 10.1016/S1474-4422(07)70178-3

B. Dubois, H. H. Feldman, C. Jacova, J. L. Cummings, S. T. Dekosky et al., Reeisig the defiitio of Alzheiee's disease: a ee leeio

M. S. Albert, S. T. Dekosky, D. Dickson, B. Dubois, H. H. Feldman et al., The diagnosis of ild ogitie ipaiet due to Alzheiee's disease: eeoeedatios fo the Natioal Institute on Aging-Alzheiee's Assoiatio okggoups o diagosti guidelies fo Alzheiee's disease

G. M. Mckhann, D. S. Knopman, H. Chertkow, B. T. Hyman, C. R. Jack-jr et al., The diagosis of deeetia due to Alzheiee's disease: eoeedatios ffo the Natioal Institute on Aging-Alzheiee's Assoiatio okggoups o diagosti guidelies fo Alzheiee's disease

C. R. Jack-jr, D. S. Knopman, S. D. Weigand, H. J. Wiste, P. Vemuri et al., An operational approach to National Institute on Aging-Alzheiee's Assoiatio iteeia for preclinical Alzheimer disease, Ann. Neurol, pp.71-765, 2012.

D. S. Knopman, C. R. Jack-jr, H. J. Wiste, S. D. Weigand, P. Vemuri et al., Short-term clinical outcomes for stages of NIA-AA preclinical Alzheimer disease, Neurology, vol.78, issue.20, pp.78-1576, 2012.
DOI : 10.1212/WNL.0b013e3182563bbe

D. S. Knopman, C. R. Jack-jr, H. J. Wiste, S. D. Weigand, P. Vemuri et al., Neuronal injury biomarkers are not dependent on ?-amyloid in normal ederly, Ann. Neurol

A. M. Fjell and K. B. Walhovd, Neuroimaging results impose ee iees o Alzheiee's disease--the role of amyloid revised, Mol. Neurobiol, pp.45-153, 2012.

K. Herrup, Commentary on « Recommendations from the National Institute on Aging- Alzheiee's Assoiatio okgoups o diagosti guidelies fo Alzheiee's disease. » Addessig the halleege of Alzheiee's disease i the st eetuu, Alzheiees Deeeet, pp.335-337, 2011.

G. Chételat, A?-independent processes: rethinking preclinical AD, Nature Review Neurology

C. R. Jack, V. J. Lowe, S. D. Weigand, H. J. Wiste, M. L. Senjem et al., Serial PIB aad MRI i oal, ild ogitie ipaieet aad Alzheiee's disease: ipliatios fo seeueeee of pathologial eeets i Alzheiee's disease

J. Sojkova, Y. Zhou, Y. An, M. A. Kraut, L. Ferrucci et al., Longitudinal patterns of ?amyloid deposition in nondemented older adults, Arch. Neurol, pp.68-644, 2011.

A. G. Vlassenko, M. A. Mintun, C. Xiong, Y. I. Sheline, A. M. Goate et al., Amyloid-beta plaque growth in cognitively normal adults: Longitudinal [11C]Pittsburgh compound B data, Annals of Neurology, vol.66, issue.5, pp.857-861, 2011.
DOI : 10.1002/ana.22608

K. Blennow and H. Zetterberg, Is it time for biomarker-based diagnostic criteria for prodromal Alzheiee's disease?, Alzheiees Res Thee

B. Draper, C. Peisah, J. Snowdon, and H. Brodaty, Early dementia diagnosis and the risk of suicide and euthanasia, Alzheimer's & Dementia, vol.6, issue.1, pp.75-82, 2010.
DOI : 10.1016/j.jalz.2009.04.1229

N. Mattsson, D. Brax, and H. Zetterberg, To Know or Not to Know: Ethical Issues Related to Early Diagnosis of Alzheimer's Disease, International Journal of Alzheimer's Disease, vol.37, issue.1
DOI : 10.1002/gps.1576

J. S. Roeets and S. M. Teseggo, Estiatig aad disslosig the isk of deeelopig Alzheiee's disease: challenges, controversies and future directions, Future Neurol, vol.5, pp.501-517, 2010.

J. Karlawish, Addressing the ethical, policy, and social challenges of preclinical Alzheimer disease, Neurology, vol.77, issue.15, pp.77-1487, 2011.
DOI : 10.1212/WNL.0b013e318232ac1a

D. Prvulovic and H. Hampel, Ethical considerations of biomarker use in neurodegenerative diseases--a ase stud of Alzheiee's disease

J. M. Wilson and G. Jungner, Principles and practice of screening for disease, 1968.

V. J. Lowe, B. J. Kemp, C. R. Jack, M. Senjem, S. Weigand et al., Comparison of 18F-FDG and PiB PET in Cognitive Impairment, Journal of Nuclear Medicine, vol.50, issue.6, p.50, 2009.
DOI : 10.2967/jnumed.108.058529

J. Koivunen, N. Scheinin, J. R. Virta, S. Aalto, T. Vahlberg et al., Amyloid PET imaging in patients with mild cognitive impairment: A 2-year follow-up study, Neurology, vol.76, issue.12, pp.76-1085, 2011.
DOI : 10.1212/WNL.0b013e318212015e

A. S. Fleisher, K. Chen, X. Liu, A. Roontiva, P. Thiyyagura et al., Using positron emission tomography and florbetapir F18 to image cortical amyloid in patients with mild cognitive impairment or dementia due to Alzheimer disease, Arch. Neurol, pp.68-1404, 2011.

R. A. Sperling, K. A. Johnson, P. M. Doraiswamy, E. M. Reiman, A. S. Fleisher et al., Amyloid deposition detected with florbetapir F 18 (18F-AV-45) is related to lower episodic memory performance in clinically normal older individuals, Neurobiology of Aging, vol.34, issue.3, pp.822-831, 2013.
DOI : 10.1016/j.neurobiolaging.2012.06.014